GlaxoSmithKline plc (Mexico) Profile

MXN 0.000024  0.00%

GlaxoSmithKline plc Summary

GlaxoSmithKline plc (GSKN) is traded on Mexico Stock Exchange in Mexico. It is located in 980 Great West Road and employs 98,462 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 2120 B. GlaxoSmithKline plc has 4.89 B outstanding shares. GLAXOSMITHKLINE A has accumulated about 5.51 B in cash with 9.74 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.25.
Check GlaxoSmithKline plc Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 871.1HorizonTargetOdds Above 871.1
?%30 days 871.10 ?%
Based on normal probability distribution, the odds of GlaxoSmithKline plc to move above current price in 30 days from now is about 0.0% (This GlaxoSmithKline plc probability density function shows the probability of GlaxoSmithKline plc Stock to fall within a particular range of prices over 30 days) .

Key Fundamentals

GlaxoSmithKline plc Against Markets

Current Ratings

GlaxoSmithKline plc 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for GlaxoSmithKline plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. GlaxoSmithKline plc is traded on Mexico Stock Exchange in Mexico. more
NameGlaxoSmithKline plc
CEO, Executive DirectorAndrew WittyView All
Macroaxis Advice
InstrumentMexico Stock View All
Business Address980 Great West Road
ExchangeMexico Stock Exchange
Contact Number44 20 8047 5000

Diversify with GlaxoSmithKline plc

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add GlaxoSmithKline plc to your portfolio


GlaxoSmithKline plc Corporate Directors
Vindi Banga Senior Independent Non-Executive Director
Lynn Elsenhans Independent Non-Executive Director
Daniel Podolsky Non-Executive Independent Director
Please also check Risk vs Return Analysis. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.